81 related articles for article (PubMed ID: 22476976)
1. Cognitive impairment as unusual first manifestation in late-onset relapsing-remitting multiple sclerosis.
Etgen T; Adler-Hunklinger U; Hemmer B
Acta Neurol Belg; 2012 Sep; 112(3):307-9. PubMed ID: 22476976
[No Abstract] [Full Text] [Related]
2. Relevance of cognitive deterioration in early relapsing-remitting MS: a 3-year follow-up study.
Amato MP; Portaccio E; Goretti B; Zipoli V; Iudice A; Della Pina D; Malentacchi G; Sabatini S; Annunziata P; Falcini M; Mazzoni M; Mortilla M; Fonda C; De Stefano N;
Mult Scler; 2010 Dec; 16(12):1474-82. PubMed ID: 20729256
[TBL] [Abstract][Full Text] [Related]
3. The relationship between regional microstructural abnormalities of the corpus callosum and physical and cognitive disability in relapsing-remitting multiple sclerosis.
Caligiuri ME; Barone S; Cherubini A; Augimeri A; Chiriaco C; Trotta M; Granata A; Filippelli E; Perrotta P; Valentino P; Quattrone A
Neuroimage Clin; 2015; 7():28-33. PubMed ID: 25610764
[TBL] [Abstract][Full Text] [Related]
4. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
[TBL] [Abstract][Full Text] [Related]
5. Cognitive impairment in multiple sclerosis: a longitudinal study.
Amato MP; Ponziani G; Amaducci L
Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():465-8. PubMed ID: 10689495
[No Abstract] [Full Text] [Related]
6. Cognitive impairment has a strong relation to nonsomatic symptoms of depression in relapsing-remitting multiple sclerosis.
Sundgren M; Maurex L; Wahlin Å; Piehl F; Brismar T
Arch Clin Neuropsychol; 2013 Mar; 28(2):144-55. PubMed ID: 23291310
[TBL] [Abstract][Full Text] [Related]
7. Dichotic listening and corpus callosum magnetic resonance imaging in relapsing-remitting multiple sclerosis with emphasis on sex differences.
Gadea M; Marti-Bonmatí L; Arana E; Espert R; Casanova V; Pascual A
Neuropsychology; 2002 Apr; 16(2):275-81. PubMed ID: 11949719
[TBL] [Abstract][Full Text] [Related]
8. Correlation of global N-acetyl aspartate with cognitive impairment in multiple sclerosis.
Mathiesen HK; Jonsson A; Tscherning T; Hanson LG; Andresen J; Blinkenberg M; Paulson OB; Sorensen PS
Arch Neurol; 2006 Apr; 63(4):533-6. PubMed ID: 16606765
[TBL] [Abstract][Full Text] [Related]
9. Symptom clusters in women with relapsing-remitting multiple sclerosis.
Newland PK; Fearing A; Riley M; Neath A
J Neurosci Nurs; 2012 Apr; 44(2):66-71. PubMed ID: 22367268
[TBL] [Abstract][Full Text] [Related]
10. Association of neocortical volume changes with cognitive deterioration in relapsing-remitting multiple sclerosis.
Amato MP; Portaccio E; Goretti B; Zipoli V; Battaglini M; Bartolozzi ML; Stromillo ML; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
Arch Neurol; 2007 Aug; 64(8):1157-61. PubMed ID: 17698706
[TBL] [Abstract][Full Text] [Related]
11. Early diffuse demyelinating lesion in the cervical spinal cord predicts a worse prognosis in relapsing-remitting multiple sclerosis.
Coret F; Bosca I; Landete L; Magraner MJ; Navarré A; León JL; Casanova B
Mult Scler; 2010 Aug; 16(8):935-41. PubMed ID: 20573640
[TBL] [Abstract][Full Text] [Related]
12. Evidence for a direct association between cortical atrophy and cognitive impairment in relapsing-remitting MS.
Morgen K; Sammer G; Courtney SM; Wolters T; Melchior H; Blecker CR; Oschmann P; Kaps M; Vaitl D
Neuroimage; 2006 Apr; 30(3):891-8. PubMed ID: 16360321
[TBL] [Abstract][Full Text] [Related]
13. Neocortical volume decrease in relapsing-remitting multiple sclerosis with mild cognitive impairment.
Portaccio E; Amato MP; Bartolozzi ML; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; De Stefano N
J Neurol Sci; 2006 Jun; 245(1-2):195-9. PubMed ID: 16631794
[TBL] [Abstract][Full Text] [Related]
14. Corpus callosum atrophy--a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.
Vaneckova M; Kalincik T; Krasensky J; Horakova D; Havrdova E; Hrebikova T; Seidl Z
Eur Neurol; 2012; 68(1):23-7. PubMed ID: 22677920
[TBL] [Abstract][Full Text] [Related]
15. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
[TBL] [Abstract][Full Text] [Related]
16. Effects of immunomodulatory treatment with subcutaneous interferon beta-1a on cognitive decline in mildly disabled patients with relapsing-remitting multiple sclerosis.
Patti F; Amato MP; Bastianello S; Caniatti L; Di Monte E; Ferrazza P; Goretti B; Gallo P; Morra VB; Lo Fermo S; Picconi O; Tola MR; Trojano M;
Mult Scler; 2010 Jan; 16(1):68-77. PubMed ID: 19995846
[TBL] [Abstract][Full Text] [Related]
17. Cognitive deficits in multiple sclerosis patients with cerebellar symptoms.
Valentino P; Cerasa A; Chiriaco C; Nisticò R; Pirritano D; Gioia M; Lanza P; Canino M; Del Giudice F; Gallo O; Condino F; Torchia G; Quattrone A
Mult Scler; 2009 Jul; 15(7):854-9. PubMed ID: 19542264
[TBL] [Abstract][Full Text] [Related]
18. Alexia without agraphia in multiple sclerosis: case report with magnetic resonance imaging localization.
Mao-Draayer Y; Panitch H
Mult Scler; 2004 Dec; 10(6):705-7. PubMed ID: 15584497
[TBL] [Abstract][Full Text] [Related]
19. Fatigue and cognition in patients with relapsing multiple sclerosis treated with interferon β.
Melanson M; Grossberndt A; Klowak M; Leong C; Frost EE; Prout M; Le Dorze JA; Gramlich C; Doupe M; Wong L; Esfahani F; Gomori A; Namaka M
Int J Neurosci; 2010 Oct; 120(10):631-40. PubMed ID: 20942577
[TBL] [Abstract][Full Text] [Related]
20. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
